Heron Therapeutics stock heads toward November 9 results
Published on 10/30/2026 at 20:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSNovember Results Set Investor Focus
- Heron Therapeutics will report third-quarter results and discuss business highlights on November 9.
- The company has scheduled the investor call and webcast for 8:30 a.m. Eastern Time.
Heron Therapeutics announced on October 26 that it will report third-quarter 2026 results and discuss recent business highlights on Monday, November 9. The announcement was carried by Quiver Quantitative from a GlobeNewswire release.
November Results Set Investor Focus
The conference call and live webcast are scheduled for 8:30 a.m. Eastern Time. Heron said the event will cover the quarterly financial results and recent business developments, with an archived version available on the company's website for 60 days.
Heron describes itself as a commercial-stage biotechnology company focused on therapeutic innovations for acute-care and oncology patients. The upcoming report is the next scheduled company update for investors following the second quarter.
The real-time quote of Heron Therapeutics stock was 0.25 euros on Lang & Schwarz at 8:47 p.m. CET on Friday, October 30, 2026.
Heron Therapeutics at a glance
- Company: Heron Therapeutics, Inc.
- ISIN: US4277461020
- Ticker: HRTX
- Primary exchange: Nasdaq
- Lang & Schwarz quote: 0.25 euros at 8:47 p.m. CET on October 30, 2026
Broader US equities are tracked through the S&P 500 market overview.
More updates are available in more news and analyses on Heron Therapeutics stock.
